Shopping Cart
- Remove All
- Your shopping cart is currently empty
Laventatug is a humanized monoclonal antibody targeting human SLC39A6. By specifically binding to SLC39A6, it disrupts the transport process of zinc ions within cells, thereby exhibiting antitumor activity. Laventatug holds potential for cancer research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
5 mg | Inquiry | Backorder |
Description | Laventatug is a humanized monoclonal antibody targeting human SLC39A6. By specifically binding to SLC39A6, it disrupts the transport process of zinc ions within cells, thereby exhibiting antitumor activity. Laventatug holds potential for cancer research. |
Cas No. | 3009829-91-5 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.